ACE and COVID-19: Importantly, the IgG-ELISA and the sVNT correlated well, indicating that both vaccines lead to high IgG titers strongly inhibiting RBD–ACE-2 interactions and thus most likely strong neutralizing effects with the promise of a much milder course of COVID-19 for all six tested SARS-CoV-2 variants.